Entity Type
Company
SEC filings, ownership reports, and insider transactions for CIK 0001809616.
Entity Type
Company
Total Filings
99
Latest Filing
18 Mar 2026
Industry
Pharmaceutical Preparations
Universe Pharmaceuticals INC has filed 99 SEC EDGAR filings since 24 Apr 2020. Common forms include 3, 6-K, 20-F, SCHEDULE 13G/A and more.
Recent SEC filings for Universe Pharmaceuticals INC with direct links to document and filing folders.
| Form type | Document | Filing | Description | Filing date | Reporting date | File number(s) |
|---|---|---|---|---|---|---|
| 3 | Open 3 document | View SEC filing for 3 | 18 Mar 2026 | 18 Mar 2026 | ||
| 3 | Open 3 document | View SEC filing for 3 | 18 Mar 2026 | 18 Mar 2026 | ||
| 3 | Open 3 document | View SEC filing for 3 | 18 Mar 2026 | 18 Mar 2026 | ||
| 3 | Open 3 document | View SEC filing for 3 | 18 Mar 2026 | 18 Mar 2026 | ||
| 3 | Open 3 document | View SEC filing for 3 | 18 Mar 2026 | 18 Mar 2026 | ||
| 3 | Open 3 document | View SEC filing for 3 | 18 Mar 2026 | 18 Mar 2026 | ||
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 11 Feb 2026 | 11 Feb 2026 | 001-40231 |
| 20-F | Open 20-F document | Open XBRL data | View SEC filing for 20-F | ANNUAL REPORT | 29 Jan 2026 | 30 Sep 2025 | 001-40231 |
| SCHEDULE 13G/A | Open SCHEDULE 13G/A document | View SEC filing for SCHEDULE 13G/A | 07 Jan 2026 | 005-93205 | ||
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 03 Sep 2025 | 03 Sep 2025 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 26 Aug 2025 | 26 Aug 2025 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 29 Jul 2025 | 29 Jul 2025 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 03 Jul 2025 | 03 Jul 2025 | 001-40231 |
| SCHEDULE 13G/A | Open SCHEDULE 13G/A document | View SEC filing for SCHEDULE 13G/A | 15 May 2025 | 005-93205 | ||
| 20-F | Open 20-F document | Open XBRL data | View SEC filing for 20-F | ANNUAL REPORT | 29 Apr 2025 | 30 Sep 2024 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 20 Mar 2025 | 20 Mar 2025 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 11 Mar 2025 | 11 Mar 2025 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 03 Mar 2025 | 03 Mar 2025 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 25 Feb 2025 | 25 Feb 2025 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 20 Feb 2025 | 20 Feb 2025 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 18 Feb 2025 | 18 Feb 2025 | 001-40231 |
| SCHEDULE 13G | Open SCHEDULE 13G document | View SEC filing for SCHEDULE 13G | 14 Feb 2025 | 005-93205 | ||
| 6-K | Open 6-K document | View SEC filing for 6-K | CURRENT REPORT | 11 Feb 2025 | 11 Feb 2025 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 03 Feb 2025 | 03 Feb 2025 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | CURRENT REPORT | 30 Jan 2025 | 30 Jan 2025 | 001-40231 |
| NT 20-F | Open NT 20-F document | View SEC filing for NT 20-F | NOTIFICATION OF LATE FILING | 27 Jan 2025 | 30 Sep 2024 | 001-40231 |
| SCHEDULE 13G | Open SCHEDULE 13G document | View SEC filing for SCHEDULE 13G | 03 Jan 2025 | 005-93205 | ||
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 12 Dec 2024 | 12 Dec 2024 | 001-40231 |
| 424B5 | Open 424B5 document | View SEC filing for 424B5 | PROSPECTUS SUPPLEMENT | 09 Dec 2024 | 333-268028 | |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 13 Nov 2024 | 13 Nov 2024 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 01 Nov 2024 | 01 Nov 2024 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 10 Oct 2024 | 10 Oct 2024 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 27 Sep 2024 | 27 Sep 2024 | 001-40231 |
| 6-K | Open 6-K document | Open XBRL data | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 20 Sep 2024 | 31 Mar 2024 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | CURRENT REPORT | 03 Sep 2024 | 03 Sep 2024 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 18 Jul 2024 | 18 Jul 2024 | 001-40231 |
| 424B4 | Open 424B4 document | View SEC filing for 424B4 | PROSPECTUS | 25 Jun 2024 | 333-278914 | |
| EFFECT | Open EFFECT document | View SEC filing for EFFECT | 07 Jun 2024 | 333-278914 | ||
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 05 Jun 2024 | |||
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 14 May 2024 | |||
| F-1/A | Open F-1/A document | View SEC filing for F-1/A | AMENDMENT NO. 1 TO FORM F-1 | 14 May 2024 | 333-278914 | |
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 08 May 2024 | 333-278914 | ||
| F-1 | Open F-1 document | View SEC filing for F-1 | REGISTRATION STATEMENT | 24 Apr 2024 | 333-278914 | |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 07 Feb 2024 | 07 Feb 2024 | 001-40231 |
| 20-F | Open 20-F document | Open XBRL data | View SEC filing for 20-F | ANNUAL REPORT | 30 Jan 2024 | 30 Sep 2023 | 001-40231 |
| 6-K | Open 6-K document | Open XBRL data | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 31 Aug 2023 | 31 Mar 2023 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 16 Aug 2023 | 16 Aug 2023 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 04 Aug 2023 | 04 Aug 2023 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 27 Jul 2023 | 27 Jul 2023 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 05 Jul 2023 | 05 Jul 2023 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | CURRENT REPORT | 24 May 2023 | 24 May 2023 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 05 May 2023 | 05 May 2023 | 001-40231 |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 14 Feb 2023 | 005-93205 | ||
| 20-F | Open 20-F document | Open XBRL data | View SEC filing for 20-F | ANNUAL REPORT | 10 Feb 2023 | 30 Sep 2022 | 001-40231 |
| NT 20-F | Open NT 20-F document | View SEC filing for NT 20-F | NOTIFICATION OF LATE FILING | 30 Jan 2023 | 30 Sep 2022 | 001-40231 |
| EFFECT | Open EFFECT document | View SEC filing for EFFECT | 15 Nov 2022 | 333-268028 | ||
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 14 Nov 2022 | 14 Nov 2022 | 001-40231 |
| F-3 | Open F-3 document | View SEC filing for F-3 | REGISTRATION STATEMENT | 27 Oct 2022 | 333-268028 | |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 28 Sep 2022 | 28 Sep 2022 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 29 Aug 2022 | 29 Aug 2022 | 001-40231 |
| 6-K | Open 6-K document | Open XBRL data | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 16 Aug 2022 | 31 Mar 2022 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 19 Jul 2022 | 19 Jul 2022 | 001-40231 |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | SCHEDULE 13G | 11 Feb 2022 | 005-93205 | |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 31 Jan 2022 | 31 Jan 2022 | 001-40231 |
| 20-F | Open 20-F document | Open XBRL data | View SEC filing for 20-F | ANNUAL REPORT | 31 Jan 2022 | 30 Sep 2021 | 001-40231 |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | UPC PURA VIDA 13G | 28 Dec 2021 | 005-93205 | |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 15 Dec 2021 | 15 Dec 2021 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 10 Dec 2021 | 10 Dec 2021 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 09 Dec 2021 | 09 Dec 2021 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 02 Aug 2021 | 02 Aug 2021 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | CURRENT REPORT | 31 Mar 2021 | 31 Mar 2021 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 25 Mar 2021 | 25 Mar 2021 | 001-40231 |
| 424B4 | Open 424B4 document | View SEC filing for 424B4 | PROSPECTUS | 24 Mar 2021 | 333-248067 | |
| EFFECT | Open EFFECT document | View SEC filing for EFFECT | 22 Mar 2021 | 333-248067 | ||
| CERT | Open CERT document | View SEC filing for CERT | 22 Mar 2021 | 001-40231 | ||
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 17 Mar 2021 | |||
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 17 Mar 2021 | |||
| 8-A12B | Open 8-A12B document | View SEC filing for 8-A12B | FORM 8-A12B | 17 Mar 2021 | 001-40231 | |
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 10 Mar 2021 | |||
| F-1/A | Open F-1/A document | View SEC filing for F-1/A | AMENDMENT NO. 4 TO FORM F-1 | 10 Mar 2021 | 333-248067 | |
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 02 Mar 2021 | |||
| FWP | Open FWP document | View SEC filing for FWP | FREE WRITING PROSPECTUS | 01 Mar 2021 | 333-248067 | |
| FWP | Open FWP document | View SEC filing for FWP | FREE WRITING PROSPECTUS | 01 Mar 2021 | 333-248067 | |
| F-1/A | Open F-1/A document | View SEC filing for F-1/A | AMENDMENT NO. 3 TO FORM F-1 | 24 Feb 2021 | 333-248067 | |
| FWP | Open FWP document | View SEC filing for FWP | FREE WRITING PROSPECTUS | 10 Dec 2020 | 333-248067 | |
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 02 Dec 2020 | |||
| F-1/A | Open F-1/A document | View SEC filing for F-1/A | AMENDMENT NO.2 TO FORM F-1 | 02 Dec 2020 | 333-248067 | |
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 19 Nov 2020 | |||
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 17 Nov 2020 | |||
| F-1/A | Open F-1/A document | View SEC filing for F-1/A | AMENDMENT NO. 1 TO FORM F-1 | 17 Nov 2020 | 333-248067 | |
| FWP | Open FWP document | View SEC filing for FWP | FREE WRITING PROSPECTUS | 23 Sep 2020 | 333-248067 | |
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 01 Sep 2020 | |||
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 17 Aug 2020 | |||
| F-1 | Open F-1 document | View SEC filing for F-1 | REGISTRATION STATEMENT | 17 Aug 2020 | 333-248067 | |
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 24 Jun 2020 | |||
| DRSLTR | Open DRSLTR document | View SEC filing for DRSLTR | 12 Jun 2020 | |||
| DRS/A | Open DRS/A document | View SEC filing for DRS/A | 12 Jun 2020 | 377-03139 | ||
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 20 May 2020 | |||
| DRS | Open DRS document | View SEC filing for DRS | 24 Apr 2020 | 377-03139 |
Universe Pharmaceuticals INC files with the SEC under CIK 0001809616. This page aggregates EDGAR filings and related ownership activity.
Industry: Pharmaceutical Preparations.